Member Info for GreenManDK

If Technical Analysis is your thing, this is the view from British Bulls:

Signal Update

Today's recommendation from our system is to STAY LONG. The previous BUY signal was issued on 18/03/2025, 21 days ago, when the stock price was 184.32. Since then, FARN.L has risen by +20.99%.

Market Outlook

The bulls have taken full control of the market. The negative sentiment that led to the last bearish pattern has dissipated. The current price is significantly distant from the confirmation level, greatly reducing the chances of a bearish confirmation. Besides, the signal is suggesting to STAY LONG. It is prudent to follow the signal and continue holding this security.

Seems to be a shoe in (based on the carnegie report and recent news article) that the data will be good, it all hinges on what we can do with that data. Is it enough to get a deal? If it is im not convinced it will happen till Q3 at the earliest

They sound pretty bullish on the upcoming results, any one have any thoughts on when in April we will see the analysis?

Surprised this wasnt announced via RNS, but here is the AGM results:

https://faron.com/releases-and-publications/results-of-the-annual-general-meeting-change-of-directors-decision-of-the-board-meeting-after-the-agm/

Why is it the "Last chance to get cheap shares today"?

I’m more and more getting the feeling we are going to be funding P3 ourselves …. Not sure I’ve got the patience for it given the narrative we’ve been fed for years but I will try to stay invested if it does happen

Good spot, i've done a little digging. One of the things that jumped out at me was this Pharma investment firm that he is on the board of, they have a history of providing significant cash to pharma companies, the sort of funds that could see us through Phase 3 trials... I really hope we are going to partner with a large pharma rather than take a huge amount of senior debt on with these guys. Just one link I made, hopefully im wrong

https://bpcruk.com/investment-strategy-portfolio/

i really dont think going p3 alone is a possibility as the narrative has always been to partner up, that would really **** off shareholders and they probably wouldn't get a resolution passed to raise the sort of funds required for that. i believe we should get p2 read out in april and then a partner announcement either at the same time or shortly after. you can see readout timeframe confirmed here:

https://faron.com/investors/faron-as-an-investment/strategy/

Yep fair enough, I only briefly cast my eye over it

Why did they do the rns last week and this one in relation to orphan status??

I'm sure Sax is doing his research before posting

Also there is no way we would have got fast track status or orphan designation as these governing bodies pour over the data before handing these out

I think my confusion is coming from the fact that the LSE website is not displaying the RNS properly. Double checked it on VOX and i can see the missing data. Agree its just dilution

So is that the pension fund selling out its whole position or have i misread the RNS?

Cairn are a lot cheaper than Peel Hunt, if there is a large transaction coming then makes sense to economise

Also lets not forget where this partnership is likely to emerge from, our recent board addition Christine Roth who is currently serving as Bayer AG, Head of Global Product Strategy and Commercialization and until the end of last year she was VP in Bayer's Oncology Strategic Business Unit. Bayer getting as close as they can to this for when Juho is satisfied the valuation is correct and deal can be struck! Bayer have seriously deep pockets!

https://faron.com/about-faron/board-of-directors/

"Sebastian Guth is promoted to the role of chief operating officer, with overall responsibility for commercial operations, from his previous role as head of Bayer’s pharma division in the US. Meanwhile, a new ‘global commercialisation’ unit bundling together oncology, marketing, digital, and parts of medical affairs and pharmacovigilance is being set up and will be led by Christine Roth, previously head of oncology."

https://pharmaphorum.com/news/guth-named-coo-bayer-revamps-top-pharma-team

Juho explicitly said they had had offers on the table, they didn't have to RNS them as the board chose not pursue as they had clearly decided on the strategy to self-fund to end of phase II trials long ago. There was a youtube interview or analyst call a few weeks ago were he said it. I think it was the one where he first eluded to raising more money to get to the end of phase II

Guys look at the quality of the scientific board we have, these are best in their field people. They would not put their name to anything they thought was a scam, a long shot, a pipe dream or any of the other negative dross I read on this board. These guys really really know and understand the IP that Faron has. It’s actually incredibly disrespectful to the board and scientific board to suggest this might be “a cesspit of financial corruption”. Have some respect for the years of work these people have committed.

Managed to get just un £5k @ 167p. should see it published shortly. Thats me done on cash for a while, have bought £30k over the last 3 weeks. Wish i had waited a bit rather than buying some of the clips just over 200p but what can you do! I wont notice in the long run!

I’ll be topping up £5k as unless there is a disaster with the data I don’t see how will be down at these levels again based on the roadmap for this year